Paiva, M.J.M.d.; D’Alessandro, W.B.; Damasceno, I.A.d.M.; Panontin, J.F.; Santos, T.T.d.; Herrera, S.D.S.C.; Santos, M.S.; Trevisan, M.
Flavonoids in Cancer Therapy: Nanocarrier Strategies to Overcome Bioavailability Limitations. Sci. Pharm. 2026, 94, 51.
https://doi.org/10.3390/scipharm94020051
AMA Style
Paiva MJMd, D’Alessandro WB, Damasceno IAdM, Panontin JF, Santos TTd, Herrera SDSC, Santos MS, Trevisan M.
Flavonoids in Cancer Therapy: Nanocarrier Strategies to Overcome Bioavailability Limitations. Scientia Pharmaceutica. 2026; 94(2):51.
https://doi.org/10.3390/scipharm94020051
Chicago/Turabian Style
Paiva, Maykon Jhuly Martins de, Walmirton Bezerra D’Alessandro, Iangla Araújo de Melo Damasceno, Juliane Farinelli Panontin, Taides Tavares dos Santos, Sávia Denise Silva Carlotto Herrera, Mateus Silva Santos, and Márcio Trevisan.
2026. "Flavonoids in Cancer Therapy: Nanocarrier Strategies to Overcome Bioavailability Limitations" Scientia Pharmaceutica 94, no. 2: 51.
https://doi.org/10.3390/scipharm94020051
APA Style
Paiva, M. J. M. d., D’Alessandro, W. B., Damasceno, I. A. d. M., Panontin, J. F., Santos, T. T. d., Herrera, S. D. S. C., Santos, M. S., & Trevisan, M.
(2026). Flavonoids in Cancer Therapy: Nanocarrier Strategies to Overcome Bioavailability Limitations. Scientia Pharmaceutica, 94(2), 51.
https://doi.org/10.3390/scipharm94020051
